Workflow
Señorita and RYTHM Make History as the First THC Beverages Available at a Major U.S. Arena
Globenewswire· 2026-01-27 12:00
Partnership marks a first for the United Center and establishes RYTHM, Inc. as the venue’s Official THC SponsorROLLING MEADOWS, Ill., Jan. 27, 2026 (GLOBE NEWSWIRE) -- The largest live entertainment venue in the United States is making history as the first major arena to offer THC beverages. Chicago’s iconic United Center has entered a new multi-year partnership with Chicago-based brands Señorita and RYTHM to make THC beverages available at concerts and live events, expanding consumer options for attendees ...
Whitestone REIT Announces Fourth Quarter 2025 Earnings Webcast and Conference Call
Globenewswire· 2026-01-27 12:00
HOUSTON, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Whitestone REIT (NYSE:WSR) (“Whitestone” or the “Company”) today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025 after the market close on Wednesday, February 25, 2026. The Company will host a webcast and conference call to discuss the results on Thursday, February 26, 2026, at 8:30 A.M. Eastern Time. The call will be led by Dave Holeman, Chief Executive Officer. The webcast and conference call acces ...
Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23
Globenewswire· 2026-01-27 12:00
NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it will report its financial results for the fourth quarter and full year 2025 on Monday, February 23, 2026, before the opening of the U.S. financial markets. Axsome management will then host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update. To participa ...
Itafos Completes Updated Preliminary Economic Assessment for the Arraias Phosphate Project
Globenewswire· 2026-01-27 12:00
Core Viewpoint - Itafos Inc. announced the results of the updated Preliminary Economic Assessment (PEA) for its Arraias Phosphate Project in Brazil, indicating robust economics and supporting the company's fertilizer restart strategy [1][3]. Project Overview - The Arraias Project is a phosphate mine located in Tocantins, Brazil, with a focus on developing non-traditional fertilizers [1][4]. - The PEA was prepared by WSP Canada Inc. and consolidates all project work to date, adhering to NI 43-101 standards [4]. Mineral Resource Estimate - The current Mineral Resource estimate includes 2 million tonnes (Mt) of Measured and Indicated Resources and 3 Mt of Inferred Resources, with specific grades for breccia and conglomerate [6][8]. - The Measured Mineral Resources consist of 1.1 Mt of breccia at 17.7% P2O5 and 0.5 Mt of conglomerate at 12.1% P2O5 [8]. - The Inferred Mineral Resources include 2.4 Mt of breccia at 15.4% P2O5 and 0.6 Mt of conglomerate at 12.0% P2O5 [8]. Economic Analysis - The life-of-mine plan is approximately 14 years, with an estimated after-tax net present value (NPV) of $70.7 million USD, an internal rate of return (IRR) of 85%, and a payback period of around 2 years [8][27]. - The project anticipates capital expenditures of $8.0 million USD for beneficiation plant upgrades to produce single superphosphate (SSP) [8][21]. Production and Operating Costs - The mine plan includes production of approximately 630,000 tonnes of Direct Application Product (DAPR), 760,000 tonnes of Partially Acidulated Product (PAPR), and 2.3 million tonnes of SSP [11][27]. - Operating costs for phosphate rock mining are estimated at $1.68 per tonne for contract mining and $0.19 per tonne for owners' costs [25]. Infrastructure and Environmental Considerations - The project has established infrastructure, including administrative buildings and a tailings dam for waste disposal [19][20]. - An Environmental and Social Impact Assessment was prepared in 2010, and all necessary permits are currently valid or under renewal [31]. Future Recommendations - The company plans to conduct further exploration drilling to upgrade inferred mineral resources and assess the economic viability of the project [33][40]. - Additional testing and analysis are recommended to optimize production and mitigate risks associated with mining operations [33][40].
CW Petroleum Corp (OTCQB: CWPE) Reports Revenues for Q4-2025, Shareholder Update
Globenewswire· 2026-01-27 12:00
Katy, Texas, Jan. 27, 2026 (GLOBE NEWSWIRE) -- CW Petroleum Corp (OTCQB: CWPE) (the “Company”), a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, today announces to its investors and future investors unaudited financial results for the fourth quarter ended December 31, 2025. Key Financial Highlights for Three Months Ended December 31, 2025, Compared to Prior Year Period: 2025 Revenues of $1.04 Million vs 2024 Revenues of $1.73 Million2025 EBITDA of $(73,814) vs 2024 EBITDA of $96,220202 ...
OTC Markets Group Welcomes Galleon Gold Corp. to OTCQX
Globenewswire· 2026-01-27 12:00
NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Galleon Gold Corp. (TSX-V: GGO; OTCQX: GGOXF), an advanced staged exploration and development company, has qualified to trade on the OTCQX® Best Market. Galleon Gold Corp. begins trading today on OTCQX under the symbol “GGOXF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on ...
Sharp Therapeutics Appoints Co-Founder Of National Gaucher Foundation And Clinical Researcher Robin Ely, M.D., To Advisory Board
Globenewswire· 2026-01-27 12:00
PITTSBURGH and TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Sharp Therapeutics Corp. ("Sharp" or the "Company") (TSX-V: SHRX) (OTCQB: SHRXF), a biotechnology company developing small-molecule therapeutics for genetic diseases, announced today the appointment of Robin Ely, M.D., the Clinical Director and co-founder of the National Gaucher Foundation (NGF), to its Advisory Board. Dr. Ely co-founded NGF in 1984 after her son was diagnosed with Gaucher disease. Dr. Ely played a pivotal role in facilitating the U. ...
Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa
Globenewswire· 2026-01-27 12:00
The trial is funded through Abu Dhabi’s Healthcare Research and Innovation FundClinical development activities will commence at Cleveland Clinic Abu Dhabi in 2026MERTK-related retinitis pigmentosa affects an estimated 60,000 patients worldwide RESEARCH TRIANGLE PARK, N.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today an ...
Lantronix and Safe Pro Group Launch Partnership to Advance AI-Driven Edge Intelligence for Defense and Autonomous Systems
Globenewswire· 2026-01-27 12:00
Joint Development of Qualcomm-Based Edge Compute Solutions Delivers Real-Time, On-Device Threat Detection for Drones and Unmanned Systems (UAS) — Without Reliance on the CloudIRVINE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (Nasdaq: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced a Memorandum of Understanding (MOU) and a Master Services Agreement (MSA) with Safe Pro Group Inc. (Nasdaq: SPAI) (“Safe Pro”), a developer of AI-enabl ...
AGF Management Limited Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Globenewswire· 2026-01-27 12:00
Reported quarterly adjusted diluted earnings per share of $0.62Total assets under management and fee-earning assets of $60.4 billionDeclared quarterly dividend per share to 12.5 cents TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- AGF Management Limited (AGF or the Company) (TSX: AGF.B) today announced financial results for the fourth quarter and fiscal year ended November 30, 2025. AGF reported total assets under management and fee-earning assets1 of $60.4 billion compared to $56.8 billion as at August 31, 202 ...